Irving S. Johnson

1.3k total citations
30 papers, 836 citations indexed

About

Irving S. Johnson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Irving S. Johnson has authored 30 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Irving S. Johnson's work include Cancer Treatment and Pharmacology (5 papers), Alkaloids: synthesis and pharmacology (3 papers) and Transgenic Plants and Applications (3 papers). Irving S. Johnson is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Alkaloids: synthesis and pharmacology (3 papers) and Transgenic Plants and Applications (3 papers). Irving S. Johnson collaborates with scholars based in United States. Irving S. Johnson's co-authors include Gordon H. Svoboda, D. R. Livengood, P. J. Simpson, Catherine G. Palmer, Norbert Neuss, C. G. Culbertson, G B Boder, Charles B. Reimer, R. N. Hull and Marvin Gorman and has published in prestigious journals such as Nature, Science and Diabetes Care.

In The Last Decade

Irving S. Johnson

28 papers receiving 729 citations

Peers

Irving S. Johnson
Comparison fields: 5 of 120
  • Molecular Biology 434
  • Oncology 143
  • Genetics 133
  • Organic Chemistry 83
  • Radiology, Nuclear Medicine and Imaging 73
Replace R. Daoust with:
R. Daoust Canada
Glenn A. Fischer United States
Grace K. Arimura United States
Max Schlamowitz United States
Masahiro Chiga United States
Hans Jörg Hacker Germany
I Covelli Italy
L. Pinteric Canada
Charles S. Schasteen United States
W.S. Bont Netherlands
R. Daoust Canada View profile →
Citations per field, relative to Irving S. Johnson
Irving S. Johnson · 1×
Citations per year, relative to Irving S. Johnson
Irving S. Johnson · 1×

Countries citing papers authored by Irving S. Johnson

Since Specialization
Citations

This map shows the geographic impact of Irving S. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irving S. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irving S. Johnson more than expected).

Fields of papers citing papers by Irving S. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irving S. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irving S. Johnson. The network helps show where Irving S. Johnson may publish in the future.

Co-authorship network of co-authors of Irving S. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Irving S. Johnson. A scholar is included among the top collaborators of Irving S. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irving S. Johnson. Irving S. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 13
2 14
3 3
4 2
5 29
6 23
7 2
8 30
9 9
10
Preclinical studies with vinglycinate, one of a series of chemically derived analogs of vinblastine.
2
11 13
12 63
13 2
14
Comparative studies with chemotherapeutic agents in biologically diverse in vitro cell systems.
7
15 48
16
Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.
123
17
Therapeutic activity of basic bisepoxides in murine leukemia and other transplantable mouse neoplasms.
2
18
Antitumor activity of glucagon.
1
19 5
20 10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026